Clinical Trial Update: Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]

View source ↗

Summary

This entry provides an update on the OPTIC-EXT long-term extension study of ADVM-022 for wet age-related macular degeneration. The trial is currently ACTIVE_NOT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration
• Wet Age-related Macular Degeneration

Drugs mentioned

• ADVM-022

Snippet

Sponsor: Adverum Biotechnologies, Inc. | Conditions: Wet Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration | Status: ACTIVE_NOT_RECRUITING